INTUMESCENT SYSTEMS LIMITED

INTUMESCENT SYSTEMS LIMITED

INTUMESCENT SYSTEMS LIMITED - Company Information

Print Friendly Version

INTUMESCENT SYSTEMS LIMITED

Company Registration Number:
02139649 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2018

Period of accounts

Start date: 01 April 2017

End date: 31 March 2018

INTUMESCENT SYSTEMS LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2018

Balance sheet
Notes

INTUMESCENT SYSTEMS LIMITED

Balance sheet

As at 31 March 2018


Notes
2018
2017


£
£
Fixed assets
Intangible assets:   0 0
Tangible assets: 2 517,458 510,254
Investments: 3 100 100
Total fixed assets: 517,558 510,354
Current assets
Stocks: 665,658 739,105
Debtors:   1,461,588 1,313,460
Cash at bank and in hand: 182,966 650
Total current assets: 2,310,212 2,053,215
Creditors: amounts falling due within one year: 4 (901,833) (1,446,898)
Net current assets (liabilities): 1,408,379 606,317
Total assets less current liabilities: 1,925,937 1,116,671
Provision for liabilities: (14,428) (14,428)
Total net assets (liabilities): 1,911,509 1,102,243
Capital and reserves
Called up share capital: 2 2
Profit and loss account: 1,911,507 1,102,241
Shareholders funds: 1,911,509 1,102,243

The notes form part of these financial statements

INTUMESCENT SYSTEMS LIMITED

Balance sheet statements

For the year ending 31 March 2018 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 15 August 2018
and signed on behalf of the board by:

Name: Mr D A Ward
Status: Director

The notes form part of these financial statements

INTUMESCENT SYSTEMS LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2018

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

INTUMESCENT SYSTEMS LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2018

2. Tangible Assets

Total
Cost £
At 01 April 2017 848,923
Additions 123,737
Disposals (27,168)
At 31 March 2018 945,492
Depreciation
At 01 April 2017 338,669
Charge for year 108,638
On disposals (19,273)
At 31 March 2018 428,034
Net book value
At 31 March 2018 517,458
At 31 March 2017 510,254

INTUMESCENT SYSTEMS LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2018

3. Fixed investments

Shares in group undertakings and participating interests:Cost:At 1 April 2017 and 31 March 2018: £100Impairment:At 1 April 2017 and 31 March 2018: £0Carrying Amount:At 31 March 2018: £100At 31 March 2017: £100

INTUMESCENT SYSTEMS LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2018

4. Creditors: amounts falling due within one year note

Bank Loans and Overdrafts: (2018) £0 (2017) £344,951Trade Creditors: (2018) £419,482 (2017) £467,658Amounts owed to group undertakings: (2018) £0 (2017) £289,816Corporation Tax: (2018) £44,954 (2017) £22,059Social Security & Other Taxes: (2018) £294,019 (2017) £223,006Other Creditors: (2018) £143,378 (2017) £99,408